Table 1.
Baseline Characteristics of Study Population.
| Characteristics | CG (n = 13) | TG (n = 12) | P |
|---|---|---|---|
| Age (year), mean (SD) | 54.3(5.2) | 55.0 (5.8) | .76 |
| Education, n (%) | |||
| <8 years of the study | 7 (54) | 7 (58) | .85 |
| >8 years of the study | 6 (46) | 5 (42) | |
| Self-reported race, n (%) | |||
| Caucasian | 8 (62) | 7 (58.3) | 1.00 |
| Non Caucasian | 5 (38) | 5 (41.7) | |
| Occupation, n (%) | |||
| Teacher | — | 1 (8.3) | .05 |
| Homemaker or cleaner | 3 (23) | 3 (25) | |
| Unemployed | 8 (62) | 4 (33.3) | |
| Sales | 2 (15) | — | |
| Retired | — | 4 (33.3) | |
| Marital status, n (%) | |||
| Single | 4 (31) | 2 (16.7) | .85 |
| Married | 7 (54) | 7 (58.3) | |
| Divorced | 1 (8) | 1 (8.3) | |
| Widow | 1 (8) | 2 (16.7) | |
| Arterial hypertension, n (%) | 4 (31) | 3 (23) | 1.00 |
| Diabetes, n (%) | 2 (15) | 1 (8) | 1.00 |
| Months since cancer diagnosis, mean (SD) | 40 (13.3) | 43.6 (19.9) | .92 |
| Cancer stage, n (%) | |||
| I | 3 (23) | 5 (42) | .43 |
| II | 9 (69) | 6 (50) | |
| III | 1 (8) | 1 (8) | |
| Chemotherapy, n (%) | 12 (92) | 9 (75) | .32 |
| Adjuvant | 7 (54) | 4 (44.4) | .67 |
| Neoadjuvant | 5 (38) | 5 (55.6) | |
| Radiotherapy, n (%) | 11 (85) | 11 (92) | 1.00 |
| Hormone therapy, n (%) | 1.00 | ||
| Tamoxifen | 11 (85) | 11 (92) | 1.00 |
| Aromatase inhibitors | 2 (15) | 1 (8) | |
| Self-reported lymphedema, n (%) | 7 (54) | 3 (25) | .22 |
| Level physical activity (MET-h/week), mean (SD) | 30.7 (32.1) | 22.2 (23.4) | .65 |
Abbreviations: CG, control group; TG, resistance training group; MET, metabolic equivalent of task.